Parexel International Corp (PRXL) Tops Q3 EPS by 2c; Boosts FY14 EPS Outlook

Parexel International Corp (NASDAQ: PRXL) reported Q3 EPS of $0.56, versus the analyst estimate of $0.54. Revenue for the quarter came in at $492.4 million versus the consensus estimate of $493.35 million.

Parexel International Corp sees FY2014 EPS of $2.11-$2.15, versus prior guidance of $2.01-$2.11 and the consensus of $2.06.

For earnings history and earnings-related data on Parexel International Corp (PRXL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• Vivos Therapeutics posts 35% revenue gain but widens net loss